BeStock  
Stocks › Biotechnology › KURA

Kura Oncology KURA

US equityMarket cap rank #3276Biotechnology
$10.67 +$0.14 (+1.33%)
Pre-market · Oct 8, 9:10 am ET · After hours $10.67 0.00%
Open$10.43
Prev close$10.53
Day range$10.32 – $10.99
Volume1.10M
Market cap$949.21M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$20.87M+36.5% YoY
Operating profit-$73.01M-0.5% YoY
Net profit-$68.33M-3.3% YoY
Diluted EPS-$0.77-2.7% YoY
Free cash flow-$63.21M-109.0% YoY
Operating cash flow-$62.55M

Revenue, last 8 quarters

$0.0Sep '24$53.9MDec '24$14.1MMar '25$15.3MJun '25$20.8MSep '25$17.3MDec '25$18.3MMar '26$20.9MJun '26

Net profit, last 8 quarters

$-54.4MSep '24$-19.2MDec '24$-57.4MMar '25$-66.1MJun '25$-74.1MSep '25$-81.0MDec '25$-73.3MMar '26$-68.3MJun '26

Diluted EPS by quarter

-0.63Sep '24-0.22Dec '24-0.66Mar '25-0.75Jun '25-0.85Sep '25-0.92Dec '25-0.83Mar '26-0.77Jun '26

Free cash flow by quarter

$-43.4MSep '24$268.8MDec '24$-72.2MMar '25$-30.2MJun '25$-83.2MSep '25$115.0MDec '25$-86.0MMar '26$-63.2MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$53.9MFY24$67.5MFY25

Profitability & balance sheet

Gross margin99.3%
Operating margin-411.9%
Net margin-384.3%
Return on equity-167.7%
Return on assets-46.7%
Return on invested capital-155.6%
Current ratio4.73
Liabilities / assets91.8%
Cash & investments$519.03M
Total debt$23.16M
Net cash (debt)$495.86M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $20.87M $18.27M $67.48M $17.34M $20.75M
Total Operating Revenue $20.87M $18.27M $67.48M $17.34M $20.75M
Cost of Revenue $243,000.00 $262,000.00 $57,000.00 – –
Gross Profit $20.63M $18.00M $67.43M – –
Operating Expense $93.64M $96.82M $371.06M $103.55M $100.75M
Selling and Admin Expenses $31.75M $31.56M $119.98M $39.14M $32.84M
-General & Admin Expense $31.75M $31.56M $119.98M $39.14M $32.84M
Research & Development $61.89M $65.26M $251.07M $64.41M $67.91M
Operating Profit -$73.01M -$78.82M -$303.63M -$86.27M -$80.00M
Net Non-Operating Interest Income (Expense) $4.69M $5.49M $25.26M $5.34M $5.88M
Non-Operating Interest Income $5.03M $5.83M $26.77M $5.69M $6.27M
Non-Operating Interest Expense $345,000.00 $336,000.00 $1.51M $346,000.00 $393,000.00
Pretax Profit -$68.32M -$73.33M -$278.37M -$80.93M -$74.12M
Tax $5,000.00 $8,000.00 $297,000.00 $71,000.00 $0.00
Net Profit -$68.33M -$73.33M -$278.67M -$81.00M -$74.12M
Profit from Continuing Operations -$68.33M -$73.33M -$278.67M -$81.00M -$74.12M
Net Income to Parent Company -$68.33M -$73.33M -$278.67M -$81.00M -$74.12M
Net Income to Common Stockholders -$68.33M -$73.33M -$278.67M -$81.00M -$74.12M
Basic EPS -$0.77 -$0.83 -$3.18 -$0.92 -$0.85
Diluted EPS -$0.77 -$0.83 -$3.18 -$0.92 -$0.85

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $587.79M $652.55M $738.36M $738.36M $649.38M
Total Current Assets $559.44M $623.78M $708.66M $708.66M $620.66M
Cash and Cash Equivalents & Short-Term Investments $519.03M $580.82M $667.24M $667.24M $549.67M
-Cash and Cash Equivalents $70.24M $39.08M $149.10M $149.10M $95.29M
-Short Term Investments $448.78M $541.74M $518.14M $518.14M $454.38M
Receivables $9.45M $9.35M $8.80M $8.80M $35.94M
-Accounts Receivable $9.45M $9.35M $8.80M $8.80M –
Inventory $2.49M $843,000.00 $413,000.00 $413,000.00 –
Other Current Assets $28.48M $32.77M $32.21M $32.21M $35.06M
Total Non-Current Assets $28.35M $28.77M $29.70M $29.70M $28.72M
Net PPE $14.62M $14.78M $15.16M $15.16M $14.94M
-Gross PPE $18.23M $18.02M $18.06M $18.06M $18.80M
-Accumulated Depreciation -$3.61M -$3.24M -$2.90M -$2.90M -$3.87M
Other Non-Current Assets $13.73M $13.99M $14.54M $14.54M $13.78M
Total Liabilities $539.36M $544.67M $564.23M $564.23M $406.84M
Total Current Liabilities $118.19M $101.50M $116.97M $116.97M $121.30M
Payables $2.45M $7.28M $5.26M $5.26M $4.67M
-Accounts Payable $2.39M $7.04M $5.02M $5.02M $4.67M
-Total Tax Payable $59,000.00 $239,000.00 $239,000.00 $239,000.00 $0.00
Current Accrued Expenses $40.41M $34.76M $39.09M $39.09M $47.52M
Short-Term Debt and Capital Lease Obligation $5.51M $1.28M $1.28M $1.28M $5.77M
-Current Debt $4.22M – – – $4.34M
-Current Capital Lease Obligation $1.29M $1.28M $1.28M $1.28M $1.43M
Current Deferred Liabilities $55.48M $47.70M $48.98M $48.98M $48.75M
Total Non-Current Liabilities $421.17M $443.17M $447.25M $447.25M $285.54M
Long Term Debt and Capital Lease Obligation $18.95M $22.99M $19.18M $19.18M $13.70M
-Long Term Debt $5.57M $9.75M $9.71M $9.71M $5.34M
-Long Term Capital Lease Obligation $13.37M $13.24M $9.47M $9.47M $8.36M
Non-Current Deferred Liabilities $398.60M $416.75M $424.91M $424.91M $268.85M
Other Non-Current Liabilities $3.62M $3.44M $3.17M $3.17M $2.98M
Total Equity $48.43M $107.88M $174.14M $174.14M $242.54M
Stockholders' Equity $48.43M $107.88M $174.14M $174.14M $242.54M
Capital Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
-Common Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.37B $1.36B $1.35B $1.35B $1.33B
Retained Earnings -$1.32B -$1.25B -$1.17B -$1.17B -$1.09B
Gains/Losses Not Affecting Retained Earnings -$1.21M -$380,000.00 $1.02M $1.02M $918,000.00
-Other Receivables – – – – $35.94M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$62.55M -$85.85M -$64.06M $117.27M -$80.63M
Net cash flow from continuing operations -$62.55M -$85.85M -$64.06M $117.27M -$80.63M
Net Income from Continuing Operations -$68.33M -$73.33M -$278.67M -$81.00M -$74.12M
Depreciation & Depletion & Amortization $369,000.00 $355,000.00 $1.03M $403,000.00 $164,000.00
Other Non-Cash Items $111,000.00 $106,000.00 $515,000.00 $103,000.00 $141,000.00
Change in Working Capital -$2.17M -$20.50M $184.44M $187.80M -$15.86M
-Change in Receivables -$98,000.00 -$544,000.00 -$6.74M $27.13M -$31.36M
-Change in Inventory -$1.64M -$430,000.00 -$413,000.00 – –
-Change in Prepaid Assets $4.34M -$562,000.00 -$15.95M $2.89M -$10.29M
-Change in Payables and Accrued Expense $5.01M -$14.19M $17.15M $2.34M $12.78M
-Change in Other Current Assets $336,000.00 $689,000.00 -$6.36M -$558,000.00 -$2.88M
-Change in Other Current Liabilities $250,000.00 $3.98M $1.04M $118,000.00 $232,000.00
-Change In Other Working Capital -$10.36M -$9.44M $195.72M $156.29M $15.66M
Net cash flow from investing $92.21M -$24.23M -$13.10M -$64.60M $93.97M
Net Cash Flow from Continuing Investing Activities $92.21M -$24.23M -$13.10M -$64.60M $93.97M
Net PPE Purchase and Sale -$656,000.00 -$128,000.00 -$6.64M -$2.32M -$2.57M
Net Investment Purchase and Sale $92.87M -$24.10M -$6.46M -$62.28M $96.53M
Financing Cash Flow $1.50M $69,000.00 $1.79M $1.14M $0.00
Net Cash Flow from Continuing Financing Activities $1.50M $69,000.00 $1.79M $1.14M $0.00
Proceeds from Stock Option Exercised $1.50M $69,000.00 $1.79M $1.14M $0.00
Ending Cash Balance $70.24M $39.08M $149.10M $149.10M $95.29M
Net Change in Cash $31.16M -$110.02M -$75.36M $53.81M $13.34M
Beginning Cash Balance $39.08M $149.10M $224.46M $95.29M $81.95M
Free Cash Flow -$63.21M -$85.98M -$70.70M $114.95M -$83.19M
Net Common Stock Issuance – – $0.00 $0.00 –

Discussion

No comments yet — be the first to weigh in on KURA.

Leave a comment

Scroll to Top